InterMune is a nimble, entrepreneurial, values-driven biotechnology leader.
And we exist to improve the lives of patients and families touched by Idiopathic Pulmonary Fibrosis (IPF). Our clear focus on pulmonology and orphan fibrotic diseases has already generated breakthrough therapies like Esbriet® (pirfenidone), the only approved treatment in Europe and Canada. Now, with the help of talented, driven people who share our commitment, it will lead to many more.
Whether you're involved in the research, development or commercialization of our groundbreaking therapies, you'll help shape a company that's growing as well as innovating. You'll be inspired by a team that's united by a strong sense of purpose. You'll thrive on the right balance of autonomy and support. And, if you're excited by change and ready to question how things are done, you'll solve problems, seize opportunities and achieve extraordinary results.
We're here to help patients who've had few options and little hope. And we're mindful of that every day. The passion we share will encourage you to do your very best work. Nothing stands still here. Nor will you.